Structure and Molecular Virology
Michael J. McGarvey
Department of Medicine, Faculty of Medicine, Imperial College London, St Mary's Hospital Campus, London, UK
Search for more papers by this authorMichael J. McGarvey
Department of Medicine, Faculty of Medicine, Imperial College London, St Mary's Hospital Campus, London, UK
Search for more papers by this authorHoward C. Thomas BSc, PhD, FRCP, FRCPath, FMedSci
Emeritus Professor of Hepatology, Department of Medicine, Imperial College London, London, UK
Search for more papers by this authorAnna S.F. Lok MD
Alice Lohrman Andrews Research Professor in Hepatology, Director of Clinical Hepatology, Professor of Internal Medicine, Associate Chair for Clinical Research, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA
Search for more papers by this authorStephen A. Locarnini MBBS, BSc(Hons), PhD, FRCPath
Head, Research & Molecular Development, Victorian Infectious Diseases Reference Laboratory, Melbourne, VIC, Australia
Search for more papers by this authorArie J. Zuckerman MD, DSc, FRCP, FRCPath, FMedSci
Emeritus Professor of Medical Microbiology, Formerly Principal and Dean, Royal Free Hospital School of Medicine
Search for more papers by this authorSummary
There have been major advances recently in several areas of hepatitis C virus (HCV). The array of host receptors important for HCV entry now includes HSGP, LDLR, CD81, SRB1, CLDN1, occludin, and NPC1L1. The interaction of host and nonstructural viral proteins is essential for genome replication. Long-range interactions between cis-acting elements in the 5′ and 3′ UTRs and the NS5B coding region may control the switching between genome replication and genome packaging into virions, as well as modulate translation. Capsid assembly also involves NS5A, NS2, NS3/4A, and viral RNA as well as core protein. HCV assembly is intimately connected to host lipid metabolism and the synthesis of very-low-density lipoproteins (VLDLs) resulting in a lipoviroparticle. Core, NS5A, NS2, NS3, and NS4B can regulate host metabolic processes. HCV proteins have been shown to compromise host defenses at many levels, such as NS3 and NS5A inhibition of interferon alpha and NS5A and NS5B inhibition of apoptosis.
References
- Dienstag JL, Alter HJ. Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective. Semin Liver Dis 1986; 6: 67–81.
- Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899–1905.
- Kiyosawa K, Tanaka E, Sodeyama T, et al. Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma. Jpn J Cancer Res 1990; 81: 1089–1091.
- Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–362.
- Choo Q-L, Richman KH, Han J, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451–2455.
- Takamizawa A, Mori C, Fuke I, et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991; 65: 1105–1113.
- Takeuchi K, Kubo Y, Boonmar S, et al. The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. J Gen Virol 1990; 71: 3027–3033.
- Miller RH, Purcell RH. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci USA 1990; 87: 2057–2061.
- Choo Q-L, Han J, Weiner A J, et al. Hepatitis C virus is a distant relative of the flaviviruses and pestiviruses. In: Proceedings of the International Meeting on Non-A, Non-B Hepatitis, Tokyo, Japan. Viral Hepatitis C, D and E. Amsterdam: Elsevier Science Publishers, 1991; pp. 47–52.
- Stapleton JT, Foung S, Muerhoff AS, et al. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV) and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol 2011; 92: 233–246.
- Martell M, Esteban JI, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66: 3225–3229.
- Simmonds P, Smith DB, McOmish F, et al. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol 1994; 75: 1053–1061.
- Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C virus viral genotypes. Hepatology 1994; 19: 1321–1324.
- Nakano T, Lau, GM, et al. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int 2012; 32: 339–345.
- Kalinina O, Norder H, Magnius LO. Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation. J Gen Virol 2004; 85: 1853–1857.
- Burbelo PD, Dubovi EJ, Simmonds P, et al. Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J Virol 2012; 86: 6171–6178.
- Lohman V, Korner F, Koch J-O, Herian U, Theilmann, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285: 110–113.
- Blight KJ, Kolykhalov A, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290: 1972–1974.
- Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11: 791–796.
- Lindenbach, BD, Evans, MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309: 623–626.
- Yi M, Villanueva RA, Thomas DL, et al. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci USA 2006; 103: 2310–2315.
- Pietschmann T, Kaul A, Koutsoudakis G, et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 2006; 103: 7408–7413.
- Kaito MS, Watanabe K, Tsukiyama-Kohara K, et al. Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 1994; 75: 1755–1760.
- Shimizu YK, Feinstone SM, Kohara M, et al. Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology 1996; 23: 205–209.
- De Vos R, Verslype C, Depla E, et al. Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies. J Hepatol 2002; 37: 370–379.
- Maillard P, Krawczynski K, Nitkiewicz J, et al. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol 2001; 75: 8240–8250.
- Gastaminza P, Dryden KA, Boyd B, et al. Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture. J Virol 2010; 84: 10999–11009.
- Merz A, Long G, Hiet M-S, et al. Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J Biol Chem 2011; 286: 3018–3032.
- Hijikata M, Shimizu YK, Kato H, et al. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 1993; 67: 1953–1958.
- Prince AM, Huima-Byron T, Parker TS, Levine DM. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J Viral Hepat 1996; 3: 11–17.
- Thomssen R, Bonk S. Virolytic action of lipoprotein lipase on hepatitis C virus in human sera. Med Microbiol Immunol 2002; 191: 17–24.
- Andre P, Komurian-Pradel F, Deforges S, et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002; 76: 6919–6928.
- André P, Komurian-Pradel F, Deforges S, et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002; 76: 6919–6928.
- Bradley, D., McCaustland, K., Krawczynski, K, et al. Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose. J Med Virol 1991; 34: 206–208.
- Nielsen, SU, Bassendine, MF, Burt, AD, et al. Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver. J Gen Virol 2004; 85: 1497–1507.
- Andre P, Perlemuter G, Budkowska A, et al. Hepatitis C virus particles and lipoprotein metabolism. Semin Liver Dis 2005; 25: 93–104.
- Takamizawa A, Mori C, Fuke I, et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991; 65: 1105–1113.
- Inchauspe G, Zebedee SL, Lee D-H, et al. Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc Natl Acad Sci USA 1991; 88: 10292–10296.
- Selby MJ, Choo Q-L, Berger K. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol 1993; 74: 1103–1113.
- Santolini E, Migliaccio G, La Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 1994; 68: 3631–3641.
- Nowak T, Farber PM, Wengler G, Wengler G. Analyses of the terminal sequences of West Nile virus structural proteins and of the in vitro translation of these proteins allow the proposal of a complete scheme of the proteolytic cleavages involved in their synthesis. Virology 1989; 169: 365–376.
- Ruiz-Linares A, Cahour A, Despres P, et al. Processing of yellow fever virus polyprotein: role of cellular proteases in maturation of the structural proteins. J Virol 1989; 63: 4199–4209.
- Lo SY, Selby MJ, Ou JH, et al. Interaction between hepatitis C virus core protein and E1 envelope protein. J Virol 1996; 70: 5177–5182.
- Suzuki R, Matsuura Y, Suzuki T, et al. Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. Hepatology 1995; 76: 53–61.
- McLauchlan J, Lemberg MK, Hope G, Martoglio B. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J 2002; 21: 3980–3988.
- Lyn RK, Kennedy DC, Stolow A, et al. Dynamics of lipid droplets induced by the hepatitis C virus core protein. Biochem Biophys Res Commun 2010; 399: 518–524.
- Ohsaki Y, Cheng J, Suzuki M, et al. Biogenesis of cytoplasmic lipid droplets: from the lipid ester globule in the membrane to the visible structure. Biochim Biophys Acta 2009; 1791: 399–407.
- Hope RG, McLauchlan J. Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. J Gen Virol 2000; 81: 1913–1925.
- Hope RG, Murphy DJ, McLauchlan J. The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins. J Biol Chem 2002; 277: 4261–4270.
- G. Perlemuter G, Sabile A, Letteron P, et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis FASEB J 2002;16: 185–194.
- Boulant S, Douglas MW, Moody L, et al. Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule- and dynein-dependent manner. Traffic 2008; 9: 1268–1282.
- Depla M, Uzbekov R, Hourioux C, et al. Ultrastructural and quantitative analysis of the lipid droplet clustering induced by hepatitis C virus core protein. Cell Mol Life Sci 2010; 67: 3151–3161.
- Herker E, Harris C, Hernandez C, et al. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 2010; 16: 1295–1298.
- Harris C, Herker E, Farese RV Jr, et al. Hepatitis C virus core protein decreases lipid droplet turnover: a mechanism for core-induced steatosis. J Biol Chem 2011; 286: 42615–42625.
- Shavinskaya A, Boulant S, Penin F, et al. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J Biol Chem 2007; 282: 37158–37169.
- Jhaveri R, Qiang G, Diehl AM. Domain 3 of hepatitis C virus core protein is sufficient for intracellular lipid accumulation. J Infect Dis 2009; 200: 1781–1788.
- Olmstead AD, Knecht W, Lazarov I, et al. Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents. PLoS Pathog 2012; 8: e1002468.
- Yao H, Ye J. Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells. J Biol Chem 2008; 283: 849–854.
- Nolandt O, Kern V, Muller H, et al. Analysis of hepatitis C virus core protein interaction domains. J Gen Virol 1997; 78: 1331–1340.
- Kushima Y, Wakita T, Hijikata M. A disulfide-bonded dimer of the core protein of hepatitis C virus is important for virus-like particle production. J Virol 2010; 84: 9118–9127.
- Kopp M, Murray CL, Jones CT, et al. Genetic analysis of the carboxy-terminal region of the hepatitis C virus core protein. J Virol 2010; 84: 1666–1673.
- Alsaleh K, et al. Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity. J Virol 2010; 84: 12515–12528.
- Jones DM, Atoom AM, Zhang X, Kottilil S, Russell RS. A genetic interaction between the core and NS3 proteins of hepatitis C virus is essential for production of infectious virus. J Virol 2011; 85: 12351–12361.
- Steinmann E, Brohm C, Kallis S, et al. Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. J Virol 2008; 82: 7034–7046.
- Chung H, Watanabe T, Kudo M, et al. Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2. J Infect Dis 2010; 202: 853–861.
- Owsianka AM, Patel AH. Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology 1999; 257: 330–340.
- Ariumi Y, Kuroki M, Abe K, et al. DDX3 DEAD-Box RNA helicase is required for hepatitis C virus RNA replication. J Virol 2007; 81: 13922–13926.
- Angus AG, Dalrymple D, Boulant S, et al. Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein. J Gen Virol 2010; 91: 122–132.
- Counihan NA, Rawlinson SM, Lindenbach BD. Trafficking of hepatitis C virus core protein during virus particle assembly. PLoS Pathog 2011; 7: e1002302.
- Chang KS, Jiang J, Cai Z, et al. Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture. J Virol 2007; 81: 13783–13793.
- Hishiki T, Shimizu Y, Tobita R, et al. Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J Virol 2010; 84: 12048–12057.
- Lai CK, Jeng KS, Machida K, et al. Hepatitis C virus egress and release depend on endosomal trafficking of core protein. J Virol 2010; 84: 11590–11598.
- Corless L, Crump CM, Griffin SD, et al. Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles. Gen Virol 2010; 91: 362–372.
- Tamai K, Shiina M, Tanaka N, et al. Regulation of hepatitis C virus secretion by the Hrs-dependent exosomal pathway. Virology 2012; 422: 377–385.
- Roohvand F, Maillard P, Lavergne JP, et al. Initiation of hepatitis C virus infection requires the dynamic microtubule network: role of the viral nucleocapsid protein. J Biol Chem 2009; 284: 13778–13791.
- Lu W, Ou JH. Phosphorylation of hepatitis C virus core protein by protein kinase A and protein kinase C. Virology 2002; 300: 20–30.
- Isoyama T, Kuge S, Nomoto A. The core protein of hepatitis C virus is imported into the nucleus by transport receptor Kap123p but inhibits Kap121p-dependent nuclear import of yeast AP1-like transcription factor in yeast cells. J Biol Chem 2002; 277: 39634–39641.
- Moriishi K, Okabayashi T, Nakai K, et al. Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. J Virol 2003; 77: 10237–10249.
- Ray RB, Lagging LM, Meyer K, et al. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res 1995; 37: 209–220.
- Bergqvist A, Rice CM. Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein. J Virol 2001; 75: 772–781.
- You LR, Chen CM, Lee YH. Hepatitis C virus core protein enhances NF-kappa B signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J Virol 1999; 73: 1672–1681.
- Marusawa H, Hijikata M, Chiba T, Shimotohno K. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 1999; 73: 4713–4720.
- Yoshida H, Kato N, Shiratori Y, et al. Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J Biol Chem 2001; 276: 16399–16405.
- Chung YM, Park KJ, Choi SY, Hwang SB, Lee SY. Hepatitis C virus core protein potentiates TNF-alpha-induced NF-kappaB activation through TRAF2-IKKbeta-dependent pathway. Biochem Biophys Res Commun 2001; 284: 15–19.
- Zhu N, Khoshnan A, Schneider R, et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 1998; 72: 3691–3697.
- Zhu N, Ware CF, Lai MM. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor. Virology 2001; 283: 178–187.
- Cho J, Baek W, Yang S, Chang J, Sung YC, Suh M. HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation. Biochim Biophys Acta 2001; 1538: 59–66.
- Moorman JP, Prayther D, McVay D, Hahn YS, Hahn CS. The C-terminal region of hepatitis C core protein is required for Fas-ligand independent apoptosis in Jurkat cells by facilitating Fas oligomerization. Virology 2003; 312: 320–329.
- Ray RB, Meyer K, Steele R, et al. Inhibition of tumor necrosis factor (TNF-α)-medicated apoptosis by hepatitis C virus core protein. J Biol Chem 1998; 273: 2256–2259.
- Wang T, Campbell RV, Yi MK, et al. Role of hepatitis C virus core protein in viral-induced mitochondrial dysfunction. J Viral Hepat 2010; 17: 784–793.
- Berg CP, Schlosser SF, Neukirchen DK, et al. Hepatitis C virus core protein induces apoptosis-like caspase independent cell death. Virol J 2009; 6: 213.
- Lu W, Lo SY, Chen M, Wu K, Fung YK, Ou JH. Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology 1999; 264: 134–141.
- Otsuka M, Kato N, Lan K, et al. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem 2000; 275: 34122–34130.
- Jin DY, Wang HL, Zhou Y, et al. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J 2000; 19: 729–740.
- Ray RB, Meyer K, Ray R. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology 2000; 271: 197–204.
- Basu A, Meyer K, Ray RB, Ray R. Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes. Virology 2002; 298: 53–62.
- Ripoli M, Barbano R, Balsamo T, et al. Hypermethylated levels of E-cadherin promoter in Huh-7 cells expressing the HCV core protein. Virus Res 2011; 160: 74–81.
- Hijikata M, Kato N, Ootsuyama Y, et al. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci USA 1991; 88: 5547–5551.
- Houghton M. Heterogeneity of the HCV genome: importance for control of the disease. In: F Deinhardt, DW Bradley, M Houghton, eds. Hepatitis C Virus: Scientific and Clinical Status. Secaucus, NJ: Advanced Therapeutic Communications, 1992; pp. 8–9.
- Lanford RE, Notvall L, Chavez D, et al. Analysis of hepatitis C virus capsid, E1 and E2/NS2 proteins expressed in insect cells. Virology 1993; 197: 225–235.
- Spaete RR, Alexander D, Rugroden ME, et al. Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells. Virology 1992; 188: 819–830.
- Cocquerel L, Meunier JC, Pillez A, Wychowski C, Dubuisson J. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J Virol 1998; 72: 2183–2191.
- Cocquerel L, Duvet S, Meunier JC, et al. The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum. J Virol 1999; 73: 2641–2649.
- Cocquerel L, Wychowski C, Minner F, Penin F, Dubuisson J. Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins. J Virol 2000; 74: 3623–3633.
- Patel J, Patel AH, McLauchlan J. The transmembrane domain of the hepatitis C virus E2 glycoprotein is required for correct folding of the E1 glycoprotein and native complex formation. Virology 2001; 279: 58–68.
- Cocquerel L, de Op Beeck A, Lambot M, et al. Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins. EMBO J 2002; 21: 2893–2902.
- Vieyres G, Thomas X, Descamps V, et al. Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. J Virol 2010; 84: 10159–10168.
- McCaffrey K, Boo I, Tewierek K, et al. Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function. J Virol 2012; 86: 3961–3974.
- Fraser J, Boo I, Poumbourios P, Drummer HE. Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry. J Biol Chem 2011; 286: 31984–31992.
- Boo I, teWierik K, Douam F, et al. Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2. Biochem J 2012; 443: 85–94.
- Albecka A, Montserret R, Krey T, et al. Identification of new functional regions in hepatitis C virus envelope glycoprotein E2. J Virol 2011; 85: 1777–1792.
- Dubuisson J, Hsu HH, Cheung RC. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and sindbis viruses. J Virol 1994; 68: 6147–6160.
- Deleersnyder V, Pillez A, Wychoski C, et al. Formation of active hepatitis C virus glycoprotein complexes. J Virol 1997; 71: 697–704.
- Harada S, Suzuki R, Ando A, et al. Establishment of a cell line constitutively expressing E2 glycoprotein of hepatitis C virus and humoral response of hepatitis C patients to the expressed protein. J Genl Virol 1995; 76: 1223–1231.
- Dubuisson J, Rice CM. Hepatitis C virus glycoprotein folding: disulphide bond formation and association with calnexin. J Virol 1996; 70: 778–786.
- Choukhi A, Ung S, Wychowski C, Dubuisson J. Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins. J Virol 1998; 72: 3851–3858.
- Cocquerel L, Quinn ER, Flint M, Hadlock KG, Foung SK, Levy S. Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody. J Virol 2003; 77: 1604–1609.
- Barth H, Schafer C, Adah MI, et al. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J Biol Chem 2003; 278: 41003–41012.
- Penin F, Combet C, Germanidis G, Frainais PO, Deleage G, Pawlotsky JM. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 2001; 75: 5703–5710.
- Basu A, Beyene A, Meyer K, Ray R. The hypervariable region 1 of the e2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system. J Virol 2004; 78: 4478–4486.
- Maillard P, Walic M, Meuleman P, et al. Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry. PLoS One 2011; 6: e26637.
- Albecka A, Belouzard S, de Op Beeck A, et al. Role of low-density lipoprotein receptor in the hepatitis C virus life cycle. Hepatology 2012; 55: 998–1007.
- Owen DM, Huang H, Ye J, Gale M Jr. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology 2009; 10: 99–108.
- Hishiki T, Shimizu Y, Tobita R, et al. Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J Virol 2010; 84: 12048–12057.
- Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science 1998; 282: 938–941.
- Krey T, d’ Alayer J, Kikuti CM, et al. The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathog 2010; 6: e1000762.
- Bankwitz D, Steinmann E, Bitzegeio J, et al. Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes. J Virol 2010; 84: 5751–5763.
- Sharma NR, Mateu G, Dreux M, Grakoui A, Cosset FL, Melikyan GB. Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion. J Biol Chem 2011; 286: 30361–30376.
- Witteveldt J, Evans MJ, Bitzegeio J, et al. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. J Gen Virol 2009; 90: 48–58.
- Bartosch B, Vitelli A, Granier C, et al. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 2003; 278: 41624–41630.
- Kapadia SB, Barth H, Baumert T, et al. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J Virol 2007; 81: 374–383.
- Catanese, MT, von Graziani R, Hahn T, et al. High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J Virol 2007; 81: 8063–8071.
- Zeisel MB, Koutsoudakis G, Schnober EK, et al. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 2007; 46: 1722–1731.
- Patel J, Patel AH, McLauchlan J. The transmembrane domain of the hepatitis C virus E2 glycoprotein is required for correct folding of the E1 glycoprotein and native complex formation. Virology 2001; 279: 58–68.
- Acton S, Rigotti A, Landschulz, KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271: 518–520.
- Catanese MT, Ansuini H, Graziani R, et al. Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants. J Virol 2010; 84: 34–43.
- Eyre NS, Drummer HE, Beard MR. The SR-BI partner PDZK1 facilitates hepatitis C virus entry. PLoS Pathog 2010; 6: e1001130.
- von Evans MJ, Hahn T, Tscherne DM, et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007; 446: 801–805.
- Meertens, L, Bertaux C, Cukierman L, et al. The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus. J Virol 2008; 82: 3555–3560.
- Farquhar MJ, Harris HJ, Diskar M, et al. Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity. J Virol 2008; 82: 8797–8811.
- Lupberger J, Zeisel MB, Xiao F, et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat Med 2011; 17: 589–595.
- Farquhar MJ, Hu K, Harris HJ, et al. Hepatitis C virus induces CD81 and claudin-1 endocytosis. J Virol 2012; 86: 4305–4316.
- Liu S, Yang W, Shen L, et al. Tight junction proteins claudin-1 and occludin control hepatitis c virus entry and are downregulated during infection to prevent superinfection. J Virol 2009: 83: 2011–2014.
- Benedicto I, Molina-Jiménez F, Bartosch B, et al. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection. J Virol 2009; 83: 8012–8020.
- Tscherne DM, von Evans MJ, Hahn T, et al. Superinfection exclusion in cells infected with hepatitis C virus. J Virol 2007; 81: 3693–3703.
- Sainz B Jr, Barretto N, Martin DN, et al. Identification of the Niemann–Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat Med 2012; 18: 281–285.
- Fletcher NF, Yang JP, Farquhar MJ, et al. Hepatitis C virus infection of neuroepithelioma cell lines. Gastroenterology 2010; 139: 1365–1374.
- Lozach PY, de Lortat-Jacob H, de Lacroix Lavalette A, et al. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 2003; 278: 20358–20366.
- Gardner JP, Durso RJ, Arrigale RR, et al. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci USA 2003; 100: 4498–4503.
- Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 1999; 285: 107–110.
- Pavio N, Romano PR, Graczyk TM, Feinstone SM, Taylor DR. Protein synthesis and endoplasmic reticulum stress can be modulated by the hepatitis C virus envelope protein E2 through the eukaryotic initiation factor 2alpha kinase PERK. J Virol 2003; 77: 3578–3585.
- Carrere-Kremer S, Montpellier-Pala C, Cocquerel L, Wychowski C, Penin F, Dubuisson J. Subcellular localization and topology of the p7 polypeptide of hepatitis C virus. J Virol 2002; 76: 3720–3730.
- Sakai A, Claire MS, Faulk K, et al. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc Natl Acad Sci USA 2003; 100: 11646–11651.
- Griffin SD, Harvey R, Clarke DS, Barclay WS, Harris M, Rowlands DJ. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria. J Gen Virol 2004; 85: 451–461.
- Griffin SD, Beales LP, Clarke DS, et al. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine. FEBS Lett 2003; 535: 34–38.
- Pavlovic D, Neville DC, Argaud O, et al. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc Natl Acad Sci USA 2003; 100: 6104–6108.
- Montserret R, Saint N, Vanbelle C, et al. NMR structure and ion channel activity of the p7 protein from hepatitis C virus. J Biol Chem 2010; 285: 31446–31461.
- Luik P, Chew C, Aittoniemi J, et al. The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy. Proc Natl Acad Sci USA 2009; 106: 12712–12716.
- Clarke Griffin D, Beales S, Gelais L, et al. Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro. J. Biol Chem 2006; 281: 37057–37068.
- Brohm C, Steinmann E, Friesland M, et al. Characterization of determinants important for hepatitis C virus p7 function in morphogenesis by using trans-complementation. J Virol 2009; 83: 11682–11693.
- Sakai A, Claire MS, Faulk K, et al. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc Natl Acad Sci USA 2003; 100: 11646–11651.
- Wozniak AL, Griffin S, Rowlands D, et al. Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production. PLoS Pathog 2010; 2: e1001087.
- 163. Boson B, Granio O, Bartenschlager R, et al. A concerted action of hepatitis C virus p7 and nonstructural protein 2 regulates core localization at the endoplasmic reticulum and virus assembly. PLoS Pathog 2011; 7: e1002144.
- Grakoui A, McCourt DW, Wychowski C, et al. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol 1993; 67: 2832–2843.
- Bartenschlager R, Ahlbom-Laake L, Mous J, Jacobsen H. Nonstructural protein 3 of the hepatitis C virus encodes a serine proteinase required for cleavage at the NS3/4 and NS4/5 junction. J Virol 1993; 67: 3835–3844.
- Pizzi E, Tramontano A, Tomei L, et al. Molecular model of the specificity pocket of the hepatitis C virus protease: implications for substrate recognition. Proc Natl Acad Sci USA 1994; 91: 888–892.
- Bartenschlager R, Lohmann V, Wilkinson T, Koch JO. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J Virol 1995; 69: 7519–7528.
- Bouffard P, Bartenschlager R, Ahlborn-Lacke L, et al. An in vitro assay for hepatitis C virus NS3 serine proteinase. Virology 1995; 209: 52–59.
- Lin C, Thomson JA, Rice CM. A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. J Virol 1995; 69: 4373–4380.
- D'Souza ED, O'Sullivan E, Amphlett EM, et al. Analysis of NS3-mediated processing of the hepatitis C virus nonstructural region in vitro. J Gen Virol 1994; 75: 3469–3476.
- Shoji I, Suzuki T, Chieda S, et al. Proteolytic activity of NS3 serine proteinase of hepatitis C virus efficiently expressed in Escherichia coli. Hepatology 1995; 22: 1648–1654.
- Tanji Y, Hijikata M, Satoh S, et al. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol 1995; 69: 1575–1581.
- Zhu H, Briggs JM. Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease. Proteins 2011; 79: 2428–2443.
- Horner SM, Park HS, Gale M Jr. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0. J Virol 2012; 86: 3112–3120.
- He Y, Weng L, Li R, et al. The N-terminal helix α(0) of hepatitis C virus NS3 protein dictates the subcellular localization and stability of NS3/NS4A complex. Virology 2012; 422: 214–223.
- Morgenstern KA, Landro JA, Hsiao K, et al. Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells. J Virol 1997; 71: 3767–3775.
- Beran RK, Pyle AM. Hepatitis C viral NS3-4A protease activity is enhanced by the NS3 helicase. J Biol Chem 2008; 283: 29929–29937.
- Steinkuhler C, Biasiol G, Brunetti M, et al. Product inhibition of the hepatitis C virus NS3 protease. Biochemistry 1998; 37: 8899–8905.
- LaPlante SR, Cameron DR, Aubry N, et al. Solution structure of substrate-based ligands when bound to hepatitis C virus NS3 protease domain. J Biol Chem 1999; 274: 18618–18624.
- Bianchi E, Orru S, Dal Piaz F, et al. Conformational changes in human hepatitis C virus NS3 protease upon binding of product-based inhibitors. Biochemistry 1999; 38: 13844–13852.
- Barbato G, Cicero DO, Cordier F, et al. Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain. EMBO J 2000; 19: 1195–1206.
- Urbani A, Bazzo R, Nardi MC, et al. The metal binding site of the hepatitis C virus NS3 protease. A spectroscopic investigation. J Biol Chem 1998; 273: 18760–18769.
- De Francesco R, Urbani A, Nardi MC, et al. A zinc binding site in viral serine proteinases. Biochemistry 1996; 35: 13282–13287.
- Stempniak M, Hostomska Z, Nodes BR, Hostomsky Z. The NS3 proteinase domain of hepatitis C virus is a zinc-containing enzyme. J Virol 1997; 71: 2881–2886.
- Love RA, Parge HE, Wickersham JA. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell 1996; 87: 331–342.
- Yan Y, Li Y, Munshi S, et al. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form. Protein Sci 1998; 7: 837–847.
- Kim JL, Morgenstern KA, Lin C, et al. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 1996; 87: 343–355.
- McCoy MA, Senior MM, Gesell JJ Ramanathan L, Wyss DF. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease cofactor complex. J Mol Biol 2001; 305: 1099–1110.
- Houghton M, Richman K, Han J, et al. Hepatitis C virus (HCV): a relative of the pestiviruses and flaviviruses. In: FB Hollinger, SM Lemon, H Margolis, editors. Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins, 1991; pp. 328–333.
- Koonin EV. Similarities in RNA helicases. Nature 1991; 352: 290.
- Kwong AD, Kim JM, Lin C. Structure and function of the hepatitis C virus NS3 helicase. Curr Top Microbiol Immunol 2000; 242: 171–196.
- Tai C-L, Chi W-K, Chen D-S, Hwang L-H. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J Virol 1996; 70: 8477–8484.
- Gwack Y, Kim DW, Han, JH, Choe J. Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein. Biochem Biophys Res Commun 1996; 225: 654–659.
- Pang PS, Jankowsky E, Planet PJ, Pyle AM. The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding. EMBO J 2002; 21: 1168–1176.
- Morgenstern KA, Landro JA, Hsiao K, et al. Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells. J Virol 1997; 71: 3767–3775.
- Rajagopal V, Gurjar M, Levin MK, et al. The protease domain increases the translocation stepping efficiency of the hepatitis C virus NS3-4A helicase. J Biol Chem 2010; 285: 17821–17832.
- Yao N, Hesson T, Cable M, et al. Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol 1997; 4: 463–467.
- Banerjee R, Dasgupta A. Specific interaction of hepatitis C virus protease/helicase NS3 with the 3′-terminal sequences of viral positive- and negative-strand RNA. J Virol 2001; 75: 1708–1721.
- Nishikawa S, Nishikawa F, Fukuda K. In vitro selection of RNA aptamers against HCV-NS3 helicase and their structural similarity with 3′(+)UTR of HCV. Nucleic Acids Res Suppl 2003;( 3): 241–242.
- Wardell AD, Errington W, Ciaramella G, Merson J, McGarvey MJ. Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein. J Gen Virol 1999; 80: 701–709.
- Lin C, Kim JL. Structure-based mutagenesis study of hepatitis C virus NS3 helicase. J Virol 1999; 73: 8798–8807.
- Min KH, Sung YC, Choi SY, Ahn BY. Functional interactions between conserved motifs of the hepatitis C virus RNA helicase protein NS3. Virus Genes 1999; 19: 33–43.
- Paolini C, De Francesco R, Gallinari P. Enzymatic properties of hepatitis C virus NS3-associated helicase. J Gen Virol 2000; 81: 1335–1345.
- Levin MK, Gurjar MM, Patel SS. ATP binding modulates the nucleic acid affinity of hepatitis C virus helicase. J Biol Chem 2003; 278: 23311–23316.
- Locatelli GA, Spadari S, Maga G. Hepatitis C virus NS3 ATPase/helicase: an ATP switch regulates the cooperativity among the different substrate binding sites. Biochemistry 2002; 41: 10332–10342.
- Sikora B, Chen Y, Lichti CF, et al. Hepatitis C virus NS3 helicase forms oligomeric structures that exhibit optimal DNA unwinding activity in vitro. J Biol Chem 2008; 283: 11516–11525.
- Beran RK, Lindenbach BD, Pyle AM. The NS4A protein of hepatitis C virus promotes RNA-coupled ATP hydrolysis by the NS3 helicase. J Virol 2009; 83: 3268–3275.
- Beran RK, Lindenbach BD, Pyle AM. The NS4A protein of hepatitis C virus promotes RNA-coupled ATP hydrolysis by the NS3 helicase. J Virol 2009; 83: 3268–3275.
- Shiryaev SA, Chernov AV, Shiryaeva TN, et al. The acidic sequence of the NS4A cofactor regulates ATP hydrolysis by the HCV NS3 helicase. Arch Virol 2011; 156: 313–318.
- Huang ZS, Wang CC, Wu HN. HCV NS3 protein helicase domain assists RNA structure conversion. FEBS Lett 2010; 584: 2356–2362.
- Chatel-Chaix L, Melançon P, Racine MÈ, et al. Y-box-binding protein 1 interacts with hepatitis C virus NS3/4A and influences the equilibrium between viral RNA replication and infectious particle production. J Virol 2011; 85: 11022–11037.
- NS4A-1. Hara H, Aizaki H, Matsuda M, et al. Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein. J Virol 2009; 83: 5137–5147.
- Fujita T, Ishido S, Muramatsu S, et al. Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus. Biochem Biophys Res Commun 1996; 229: 825–831.
- Ishido S, Hotta H. Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor. FEBS Lett 1998; 438: 258–262.
- Ishido S, Muramatsu S, Fujita T, et al. Wild-type but not mutant type p53 enhances nuclear accumulation of the NS3 protein of hepatitis C virus. Biochem Biophys Res Commun 1997; 230: 431–436.
-
Errington W,
Wardell AD,
McDonald S,
Goldin RD,
McGarvey MJ.
Subcellular localisation of NS3 in HCV-infected hepatocytes.
J Med Virol
1999;
59:
456–462.
10.1002/(SICI)1096-9071(199912)59:4<456::AID-JMV6>3.0.CO;2-0 CAS PubMed Web of Science® Google Scholar
- Iwai A, Hasumura Y, Nojima T, Takegami T. Hepatitis C virus nonstructural protein NS3 binds to Sm-D1, a small nuclear ribonucleoprotein associated with autoimmune disease. Microbiol Immunol 2003; 47: 601–611.
- Li K, Foy E, Ferreon JC, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 2005; 102: 2992–2997.
- Li X-D, Sun L, Seth R, et al. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci USA 2005; 102: 17717–17722.
- Carvajal-Yepes M, Himmelsbach K, Schaedler S, et al. Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins. Biol Chem 2011; 286: 8941–8951.
- Arnaud N, Dabo S, Maillard P, et al. Hepatitis C virus controls interferon production through PKR activation. PLoS One 2010; 5: e10575.
- Brenndörfer ED, Karthe J, Frelin L, et al. Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase. Hepatology 2009; 49: 1810–1820.
- Behrens S-E, Tomei L, De Francesco R. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J 1996; 15: 12–22.
- Lesburg CA, Cable MB, Ferrari E, Hong Z, Mannarino AF, Weber PC. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol 1999; 6: 937–943.
- O'Farrell D, Trowbridge R, Rowlands D, Jager J. Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): structural evidence for nucleotide import and de-novo initiation. J Mol Biol 2003; 326: 1025–1035.
- Labonte P, Morin N, Bowlin T, Mounir S. Basal replication of hepatitis C virus in nude mice harboring human tumor. J Med Virol 2002; 66: 312–319.
- Kim M, Kim H, Cho SP, Min MK. Template requirements for de novo RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase on the viral X RNA. J Virol 2002; 76: 6944–6956.
- Oh JW, Sheu GT, Lai MM. Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template. J Biol Chem 2000; 275: 17710–17717.
- Scrima N, Caillet-Saguy C, Ventura M, et al. Two crucial early steps in RNA synthesis by the hepatitis C virus polymerase involve a dual role of residue 405. J Virol 2012; 86: 7107–7117.
- Harrus D, Ahmed-El-Sayed N, Simister PC, et al. Further insights into the roles of GTP and the C terminus of the hepatitis C virus polymerase in the initiation of RNA synthesis. J Biol Chem 2010; 285: 32906–32918.
- Wang M, Ng KK, Cherney MM, et al. Non-nucleoside analogue inhibitors bind to an allosteric site on HCV NS5B polymerase: crystal structures and mechanism of inhibition. J Biol Chem 2003; 278: 9489–9495.
- Leveque VJ, Johnson RB, Parsons S, et al. Identification of a C-terminal regulatory motif in hepatitis C virus RNA-dependent RNA polymerase: structural and biochemical analysis. J Virol 2003; 77: 9020–9028.
- Qin W, Luo H, Nomura T, Hayashi N, Yamashita T, Murakami S. Oligomeric interaction of hepatitis C virus NS5B is critical for catalytic activity of RNA-dependent RNA polymerase. J Biol Chem 2002; 277: 2132–2137.
- Wang QM, Hockman MA, Staschke K, et al. Oligomerization and cooperative RNA synthesis activity of hepatitis C virus RNA-dependent RNA polymerase. J Virol 2002; 76: 3865–3872.
- Chinnaswamy S, Murali A, Li P, et al. Regulation of de novo-initiated RNA synthesis in hepatitis C virus RNA-dependent RNA polymerase by intermolecular interactions. J Virol 2010; 84: 5923–5935.
- Schmidt-Mende J, Bieck E, Hugle T, et al. Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem 2001; 276: 44052–44063.
- Lee KJ, Choi J, Ou JH, Lai MM. The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo. J Virol 2004; 78: 3797–3802.
- Sir D, Kuo CF, Tian Y, et al. Replication of hepatitis C virus RNA on autophagosomal membranes. J Biol Chem 2012; 287: 18036–18043.
- Guévin C, Manna D, Bélanger C, et al. Autophagy protein ATG5 interacts transiently with the hepatitis C virus RNA polymerase (NS5B) early during infection. Virology 2010; 405: 1–7.
- Kaneko T, Tanji Y, Satoh S, et al. Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem Biophys Res Commun 1994; 205: 320–326.
- Koch JO, Bartenschlager R. Modulation of hepatitis C virus NS5A hyperphosphorylation by non-structural proteins NS3, NS4A, and NS4B. J Virol 1999; 73: 7138–7146.
- Reed KE, Rice CM. Identification of the major phosphorylation site of the hepatitis C virus H strain NS5A protein as serine 2321. J Biol Chem 1999; 274: 28011–28018.
- Brass V, Bieck E, Montserret R, et al. An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J Biol Chem 2002 8; 277: 8130–8199.
- Hwang J, Huang L, Cordek DG, et al. Hepatitis C virus nonstructural protein 5A: biochemical characterization of a novel structural class of RNA-binding proteins. J Virol 2010; 84: 12480–12491.
- Foster TL, Belyaeva T, Stonehouse NJ, et al. All three domains of the hepatitis C virus nonstructural NS5A protein contribute to RNA binding. J Virol 2010; 84: 9267–9277.
- Foster TL, Gallay P, Stonehouse NJ, et al. Cyclophilin A interacts with domain II of hepatitis C virus NS5A and stimulates RNA binding in an isomerase-dependent manner. J Virol 2011; 85: 7460–7464.
- Yang F, Robotham JM, Grise H, et al. A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach. PLoS Pathog 2010; 6: e1001118.
- Verdegem D, Badillo A, Wieruszeski JM, et al. Domain 3 of NS5A protein from the hepatitis C virus has intrinsic alpha-helical propensity and is a substrate of cyclophilin A. J Biol Chem 2011; 286: 20441–20454.
- Chatterji U, Bobardt MD, Lim P, et al. Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexes. J Gen Virol 2010; 91: 1189–1193.
- Reiss S, Rebhan I, Backes P, et al. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 2011; 9: 32–45.
- Lim YS, Hwang SB. Hepatitis C virus NS5A protein interacts with phosphatidylinositol 4-kinase type III alpha and regulates viral propagation. J Biol Chem 2011; 286: 11290–11298.
- Pfannkuche A, Büther K, Karthe J, et al. c-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: a prerequisite for replication. Hepatology 2011; 53: 1127–1136.
- Nevo-Yassaf I, Yaffe Y, Asher M, et al. Role for TBC1D20 and Rab1 in hepatitis C virus replication via interaction with lipid droplet-bound nonstructural protein 5A. J Virol 2012; 86: 6491–6502.
- Masaki T, Suzuki R, Murakami K, et al. Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol 2008; 82: 7964–7976.
- Appel N, Zayas M, Miller S, et al. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 2008; 4: e1000035.
- Tellinghuisen TL, Foss KL, Treadaway J. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog 2008; 4: e1000032.
- Backes P, Quinkert D, Reiss S, et al. Role of annexin A2 in the production of infectious hepatitis C virus particles. J Virol 2010; 84: 5775–5789.
- Cun W, Jiang J, Luo G. The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus. J Virol 2010; 84: 11532–11541.
- Enomoto N, Sakuma I, Asahina Y, et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. J Clin Invest 1995; 96: 224–230.
- Gale M Jr, Blakely CM, Kwieciszewski B, et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 1998; 18: 5208–5218.
- Mankouri J, Dallas ML, Hughes ME, et al. Suppression of a pro-apoptotic K+ channel as a mechanism for hepatitis C virus persistence. Proc Natl Acad Sci USA 2009; 106: 15903–15908.
- Tamura R, Kanda T, Imazeki F, et al. Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4. J Infect Dis 2011; 204: 793–801.
- Peng L, Liang D, Tong W, et al. Hepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTOR. Biol Chem 2010; 285: 20870–20881.
- George A, Panda S, Kudmulwar D, et al. Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation. J Biol Chem 2012; 287: 5042–5058.
- Ghosh AK, Majumder M, Steele R, Meyer K, Ray R, Ray RB. Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death. Virus Res 2000; 67: 173–178.
- Majumder M, Ghosh AK, Steele R, et al. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology 2002; 294: 94–105.
- Sène D, Levasseur F, Abel M, et al. Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines. PLoS Pathog 2010; 6: e1001184.
- Mazumdar B, Kim H, Meyer K, et al. Hepatitis C virus proteins inhibit C3 complement production. J Virol 2012; 86: 2221–2228.
- Xiang Z, Qiao L, Zhou Y, et al. Hepatitis C virus nonstructural protein-5A activates sterol regulatory element-binding protein-1c through transcription factor Sp1. Biochem Biophys Res Commun 2010; 402: 549–553.
- Deng L, Shoji I, Ogawa W, et al. Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol 2011; 85: 8556–8568.
- Majumder M, Ghosh AK, Steele R, Ray R, Ray RB. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 2001; 75: 1401–1407.
- Lan KH, Sheu ML, Hwang SJ, et al. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 2002; 21: 4801–4811.
- Tan SL, Nakao H, He Y, et al. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci USA 1999; 96: 5533–5538.
- He Y, Nakao H, Tan SL, et al. Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J Virol 2002; 76: 9207–9217.
- Macdonald A, Crowder K, Street A, McCormick C, Saksela K, Harris M. The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling. J Biol Chem 2003; 278: 17775–17784.
- Macdonald A, Crowder K, Street A, McCormick C, Harris M. The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J Gen Virol 2004; 85: 721–729.
- Milward A, Mankouri J, Harris M. Hepatitis C virus NS5A protein interacts with beta-catenin and stimulates its transcriptional activity in a phosphoinositide-3 kinase-dependent fashion. J Gen Virol 2010; 91: 373–381.
- Park CY, Choi SH, Kang SM, et al. Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J Hepatol 2009; 51: 853–864.
- Mizushima H, Hijikata M, Tanji Y, et al. Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2. J Virol 1994; 68: 2731–2734.
- Grakoui A, Wychowski C, Lin C, et al. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993a; 67: 1385–1395.
- Schregel V, Jacobi S, Penin F, et al. Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3. Proc Natl Acad Sci USA 2009; 106: 5342–5347.
- Reed KE, Grakoui A, Rice CM. Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage. J Virol 1995; 69: 4127–4136.
- Santolini E, Pacini L, Fipaldini C, et al. The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J Virol 1995; 69: 7461–7471.
- Popescu CI, Callens N, Trinel D, et al. NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly. PLoS Pathog 2011; 7: e1001278.
- Jirasko V, Montserret R, Lee JY, et al. Structural and functional studies of nonstructural protein 2 of the hepatitis C virus reveal its key role as organizer of virion assembly. PLoS Pathog 2010; 6: e1001233.
- Ma Y, Anantpadma M, Timpe JM, et al. Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by interacting with both structural and nonstructural proteins. J Virol 2011; 85: 86–97.
- Welbourn S, Jirasko V, Breton V, et al. Investigation of a role for lysine residues in non-structural proteins 2 and 2/3 of the hepatitis C virus for their degradation and virus assembly. J Gen Virol 2009; 90: 1071–1080.
- Erdtmann L, Franck N, Lerat H, et al. The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J Biol Chem 2003; 278: 18256–18264.
- Oem JK, Jackel-Cram C, Li YP, et al. Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2. J Gen Virol 2008; 89: 1225–1230.
- Egger D, Wolk B, Gosert R, et al. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 2002; 76: 5974–5984.
- Gosert R, Egger D, Lohmann V, et al. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J Virol 2003; 77: 5487–5492.
- Paul D, Romero-Brey I, Gouttenoire J, et al. NS4B self-interaction through conserved C-terminal elements is required for the establishment of functional hepatitis C virus replication complexes. J Virol 2011; 85: 6963–6976.
- Welker MW, Welsch C, Meyer A, et al. Dimerization of the hepatitis C virus nonstructural protein 4B depends on the integrity of an aminoterminal basic leucine zipper. Protein Sci 2010; 19: 1327–1336.
- Jones DM, Patel AH, Targett-Adams P, et al. The hepatitis C virus NS4B protein can trans-complement viral RNA replication and modulates production of infectious virus. J Virol 2009; 83: 2163–2177.
- Han Q, Aligo J, Manna D, et al. Conserved GXXXG- and S/T-like motifs in the transmembrane domains of NS4B protein are required for hepatitis C virus replication. J Virol 2011; 85: 6464–6479.
- Aligo J, Jia S, Manna D, et al. Formation and function of hepatitis C virus replication complexes require residues in the carboxy-terminal domain of NS4B protein. Virology 2009; 393: 68–83.
- Su WC, Chao TC, Huang YL, et al. Rab5 and class III phosphoinositide 3-kinase Vps34 are involved in hepatitis C virus NS4B-induced autophagy. J Virol 2011; 85: 10561–10571.
- Li S, Ye L, Yu X, et al. Hepatitis C virus NS4B induces unfolded protein response and endoplasmic reticulum overload response-dependent NF-kappaB activation. Virology 2009; 391: 257–264.
- Zhao P, Han T, Guo JJ, et al. HCV NS4B induces apoptosis through the mitochondrial death pathway. Virus Res 2012; 169: 1–7.
- Park CY, Jun HJ, Wakita T, et al. Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway. J Biol Chem 2009; 284: 9237–9246.
- Konan KV, Giddings TH Jr, Ikeda M, Li K, Lemon SM, Kirkegaard K. Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus. J Virol 2003; 77: 7843–7855.
- Kato J, Kato N, Yoshida H, Ono-Nita SK, Shiratori Y, Omata M. Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo. J Med Virol 2002; 66: 187–199.
- Florese RH, Nagano-Fujii M, Iwanaga Y, Hidajat R, Hotta H. Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus. Virus Res 2002; 90: 119–131.
- Grace K, Gartland M, Karayiannis P, McGarvey MJ, Clarke B. The 5′ untranslated region of GB virus B shows functional similarity to the internal ribosome entry site of hepatitis C virus. J Gen Virol 1999; 80: 2337–2341.
- Brown EA, Zhang H, Ping L-H, Lemon SM. Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 1992; 20: 5041–5045.
- Honda M, Beard MR, Ping LH, Lemon SM. A phylogenetically conserved stem-loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol 1999; 73: 1165–1174.
-
Kettinen H,
Grace K,
Grunert S, et al.
Mapping of the internal ribosomal entry site at the 5′ end of the hepatitis C virus genome. In:
K Nishioka,
H Suzuki,
S Mishiro,
T Oda, editors.
Viral Hepatitis and Liver Disease.
Tokyo:
Springer-Verlag,
1994; pp.
125–131.
10.1007/978-4-431-68255-4_34 Google Scholar
- Reynolds JE, Kaminski A, Kettinen HJ. Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J 1995; 14: 6010–6020.
- Honda M, Ping L-H, Rijnbrand RC, et al. Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology 1996; 222: 31–42.
- Beales LP, Rowlands DJ, Holzenburg A. The internal ribosome entry site (IRES) of hepatitis C virus visualized by electron microscopy. RNA 2001; 7: 661–670.
- Lukavsky PJ, Kim I, Otto GA, Puglisi JD. Structure of HCV IRES domain II determined by NMR. Nat Struct Biol 2003; 10: 1033–1038.
- Kim YK, Lee SH, Kim CS, Seol SK, Jang SK. Long-range RNA-RNA interaction between the 5′ nontranslated region and the core-coding sequences of hepatitis C virus modulates the IRES-dependent translation. RNA 2003; 9: 599–606.
- Honda M, Brown EA, Lemon SM. Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation of hepatitis C virus RNA. RNA 1996; 2: 955–968.
- Tanaka Y, Shimoike T, Ishii K, et al. Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5′ untranslated region of the viral genome. Virology 2000; 270: 229–236.
- Ali N, Pruijn GJ, Kenan DJ, Keene JD, Siddiqui A. Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation. J Biol Chem 2000; 275: 27531–27540.
- Pestova TV, Shatsky IN, Fletcher SP, Jackson RJ, Hellen CT. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev 1998; 12: 67–83.
- Kieft JS, Zhou K, Jubin R, Murray MG, Lau JYN, Doudna JA. The hepatitis C virus independent ribosomal entry site adopts an ion-dependent tertiary fold. J Mol Biol 1999; 292: 513–528.
- Kieft JS, Zhou K, Jubin R, Doudna JA. Mechanism of ribosomal recruitment by hepatitis C IRES RNA. RNA 2001; 7: 194–206.
- Pérard J, Rasia R, Medenbach J, et al. Human initiation factor eIF3 subunit B interacts with HCV IRES RNA through its N-terminal RNA recognition motif. FEBS Lett 2009; 583: 70–74.
- Ujino S, Nishitsuji H, Sugiyama R, et al. The interaction between human initiation factor eIF3 subunit C and heat-shock protein 90: a necessary factor for translation mediated by the hepatitis C virus internal ribosome entry site. Virus Res 2012; 163: 390–395.
- Spahn CM, Kieft JS, Grassucci RA, et al. Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal subunit. Science 2001; 291: 1959–1962.
- Wang L, Jeng KS, Lai MM. Poly( C)-binding protein 2 interacts with sequences required for viral replication in the hepatitis C virus (HCV) 5′ untranslated region and directs HCV RNA replication through circularizing the viral genome. J Virol 2011; 85: 7954–7964.
- Toroney R, Nallagatla SR, Boyer JA, et al. Regulation of PKR by HCV IRES RNA: importance of domain II and NS5A. J Mol Biol 2010; 400: 393–412.
- Díaz-Toledano R, Ariza-Mateos A, Birk A, et al. In vitro characterization of a miR-122-sensitive double-helical switch element in the 5′ region of hepatitis C virus RNA. Nucleic Acids Res 2009; 37: 5498–5510.
- Pang PS, Pham EA, Elazar M, et al. Structural map of a microRNA-122: hepatitis C virus complex. J Virol 2012; 86: 1250–1254.
- Machlin ES, Sarnow P, Sagan SM. Masking the 5′ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc Natl Acad Sci USA 2011; 108: 3193–3198.
- Shimakami T, Yamane D, Jangra RK, et al. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci USA 2012; 109: 941–946.
- Shimakami T, Yamane D, Welsch C, et al. Base-pairing between hepatitis C virus RNA and miR-122 3′ of its seed sequence is essential for genome stabilization and production of infectious virus. J Virol 2012; 86: 7372–7383.
- Scheller N, Mina LB, Galão RP, et al. Translation and replication of hepatitis C virus genomic RNA depends on ancient cellular proteins that control mRNA fates. Proc Natl Acad Sci USA 2009; 106: 13517–13522.
- Narbus CM, Israelow B, Sourisseau M, et al. HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle. J Virol 2011; 85: 12087–12092.
- Fehr C, Conrad KD, Niepmann M. Differential stimulation of hepatitis C virus RNA translation by microRNA-122 in different cell cycle phases. Cell Cycle 2012; 11: 277–285.
- Dreux M, Gastaminza P, Wieland SF, et al. The autophagy machinery is required to initiate hepatitis C virus replication. Proc Natl Acad Sci USA 2009; 106: 14046–14051.
- Ariumi Y, Kuroki M, Kushima Y, et al. Hepatitis C virus hijacks P-body and stress granule components around lipid droplets. J Virol 2011; 85: 6882–6892.
- Kolykhalov AA, Feinstone, SM, Rice CM. Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA. J Virol 1996; 70: 3363–3371.
- You S, Rice CM. 3′ RNA elements in hepatitis C virus replication: kissing partners and long poly(U). J Virol 2008; 82: 184–195.
- Diviney S, Tuplin A, Struthers M, et al. A hepatitis C virus cis-acting replication element forms a long-range RNA–RNA interaction with upstream RNA sequences in NS5B. J Virol 2008; 82: 9008–9022.
- Romero-López C, Berzal-Herranz A. The functional RNA domain 5BSL3.2 within the NS5B coding sequence influences hepatitis C virus IRES-mediated translation. Cell Mol Life Sci 2012; 69: 103–113.
- Shetty S, Kim S, Shimakami T, et al. Hepatitis C virus genomic RNA dimerization is mediated via a kissing complex intermediate. RNA 2010; 16: 913–925.
- Gontarek RR, Gutshall LL, Herold KM, et al. hnRNP C and polypyrimidine tract-binding protein specifically interact with the pyrimidine-rich region within the 3′ NTR of the HCV RNA genome. Nucleic Acids Res 1999; 27: 1457–1463.
- Ito T, Lai MM. Determination of the secondary structure of and cellular protein binding to the 3′-untranslated region of the hepatitis C virus RNA genome. J Virol 1997; 71: 8698–8706.
- Ito T, Tahara SM, Lai MM. The 3′-untranslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site. J Virol 1998; 72: 8789–8796.
- Yanagi M, St Claire M, Emerson SU, Purcell RH, Bukh J. In vivo analysis of the 3′ untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone. Proc Natl Acad Sci USA 1999; 96: 2291–2295.
- Kolykhalov AA, Mihalik K, Feinstone SM, Rice CM. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo. J Virol 2000; 74: 2046–2051.
- Friebe P, Bartenschlager R. Genetic analysis of sequences in the 3′ nontranslated region of hepatitis C virus that are important for RNA replication. J Virol 2002; 76: 5326–5338.
- Yi M, Lemon SM. 3′ nontranslated RNA signals required for replication of hepatitis C virus RNA. J Virol 2003; 77: 3557–3568.